Hi ,

We all know how hard it is to bring a novel therapeutic to market, from scientific and manufacturing challenges through the regulatory obstacle course. That's why SynBioBeta, bit.bio and Mintz are hosting a Regulatory Insights and Manufacturing Strategies Breakfast on Sept. 20th during Biotech Week Boston. Network with fellow leaders and hear from industry experts, including Jeffrey Baker, former Deputy Director of Biotechnology Products at the FDA, on what it takes to bring a therapy to market. 

Are you a biotech leader who should be in this room? Reach out to us to join!

• Where Infant Formula Falls Short Synthetic Biology Comes Up Strong. Combining AI-based enzyme engineering and cell-free systems could half the cost of essential infant formula ingredients. Here’s what companies on the cutting edge of enzyme engineering are doing about it.

• PNP Editing: The New Kid on the Gene-Editing Block. In the vast ocean of genome-editing techniques, PNP editing is making waves.

• Antheia’s Monumental Commercial Achievement. Antheia announced the triumphant wrap-up of a groundbreaking 116,000L scale manufacturing run, showcasing a commercially valuable fermentation titer for their inaugural product.

Christina Smolke, PhD, CEO and co-founder of Antheia.

The deadline on our call for speakers for SynBioBeta 2024: The Global Synthetic Biology Conference is September 8th and is quickly approaching. We want to hear from you! We aim to bring even more diverse voices to the forefront of the conversation around synthetic biology, and we are looking for speakers to share their expertise, spark thoughtful discussions, and lead education sessions for various aspects of SynBio. It will be our biggest event yet—we expect over 3,000 attendees! We can’t wait to see you there.

• Ginkgo & Google Cloud: When Biology Meets AI in a Groundbreaking Alliance. Ginkgo Bioworks inks a five-year alliance with Google Cloud, emphasizing the increasing importance of integrating AI into the biotechnology landscape, especially as companies strive to enhance their biosecurity and cell programming capabilities.

• Using Biomimicry to Harvest Water from Thin Air. University of Waterloo researchers use biomimicry to design groundbreaking surfaces to capture and convert atmospheric moisture into drinkable water, drawing inspiration from spiders and desert beetles.

• Cellares Secures $255M to Revolutionize Cell Therapy Production with IDMO Smart Factories. “The creation of the first IDMO marks the beginning of a new era, in which cell therapies will finally be able to reach patients in need,” said Cellares CEO Fabian Gerlinghaus.

• Y Not? Full Sequence of Y Chromosome Finally Assembled. A pioneering study has now revealed the last piece of the puzzle of the human genome.

• From Rats to Riches: Are Mole Rats the Key to a Longer Life? A team of researchers at the University of Rochester has achieved a remarkable feat - the successful transfer of a longevity gene from the naked mole rat to mice, resulting in improved health and an extension of the mouse’s lifespan.

Other news:

• Synthego and bit. Bio expand strategic partnership to build a platform for developing safer and more efficient genetic engineering of human cells for cell therapies. (Press release)

• Kyverna Therapeutics extends Series B financing round to $145 million and brings in new investors. Proceeds to support clinical development of novel fully human anti-CD19 CAR T-cell therapies for autoimmune diseases. (Press release)

• Concentric by Ginkgo and CGIAR International Livestock Research Institute (ILRI) announce collaboration on pathogen surveillance. This collaboration aims to develop and deploy novel methods for pandemic surveillance among animals and livestock. (Press release)

• Register now for the DC Biosecurity Happy Hour, an informal event for biosecurity professionals in DC to get to know each other outside of Zoom calls and talk about new ideas in this space.

Regards,
John

---

John Cumbers

CEO, SynBioBeta

Who's hiring?

• Surface Chemist at Elegen (San Carlos, CA)
  

• Senior Software Engineer at Elegen (San Carlos, CA)
  

• Senior NPI Engineer at Elegen (San Carlos, CA)

• Associate Director, Product Management (DNA Synthesis) at Elegen Bio (San Carlos, CA)

• Senior Field Applications Scientist at bit.Bio (Cambridge, UK)

• Account Manager/Senior Account Manager at bit.Bio (West Coast, US)

• Senior Bioinformatics Engineer at Ginkgo Bioworks (Remote)

• Engineering Manager / Epidemiology and Modeling at Ginkgo Bioworks (Remote)

• Head of Product and Technology at Ginkgo Bioworks (Remote)

• Staff Machine Learning Engineer at Absci (Remote)

• Senior AI Research Scientist at Absci (Remote)

• AI Scientist, Deep Learning at Absci (Remote)

• Sales Associate at SynBioBeta (Remote)

• Senior Scientific Implementation Manager at Ganymede (Remote)

• Senior Scientific Software Engineer at Ganymede (Remote)

• Software Engineer (Full-stack) at Ganymede (Remote)

• Business Development Associate at Ganymede (Remote)

• Outbound Sales Development at LatchBio (San Francisco, CA)